The VanEck Pharmaceutical ETF (PPH) experienced a significant $253.1 million outflow this week, marking a 19.6% decrease in shares outstanding, from 12,488,138 to 10,038,138 units. This change highlights investor shifts in the pharmaceutical sector and comes at a time when major components of the ETF, including Novartis (NVS), Sanofi (SNY), and Novo-Nordisk AS (NVO), have seen declines of approximately 1.5%, 1.8%, and 0.9%, respectively.
Currently, PPH’s share price is $101.71, with a 52-week low of $77.67 and a high of $112.58. The outflows might impact the underlying holdings, influencing market dynamics within the sector.
